Page 154 - Fluorescence-guided cancer surgery

152
Chapter 9
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
Kalli KR, Oberg AL, Keeney GL et al. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol 2008;108:619- 626.
O’Shannessy DJ, Somers EB, Smale R, Fu YS. Expression of folate receptor-alpha (FRA) in gynecologic malignancies and its relationship to the tumor type. Int J Gynecol Pathol 2013;32:258-268.
Parker N, Turk MJ, Westrick E, Lewis JD, low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005;338:284-293.
Crane LM, Arts HJ, van OM et al. The e ect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Cell Oncol (Dordr ) 2012;35:9-18.
Despierre E, Lambrechts S, Leunen K et al. Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy. Gynecol Oncol 2013;130:192-199.
O’Shannessy DJ, Somers EB, Maltzman J, Smale R, Fu YS. Folate receptor alpha (FRA) expression in breast cancer: identi cation of a new molecular subtype and association with triple negative disease. Springerplus 2012;1:22.
Liu TW, Stewart JM, Macdonald TD et al. Biologically-targeted detection of primary and micro-metastatic ovarian cancer. Theranostics 2013;3:420-427.
Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, low PS. A folate receptor- alpha-speci c ligand that targets cancer tissue and not sites of in ammation. J Nucl Med 2012;53:1127-1134.
Kennedy MD, Jallad KN, Thompson DH, Ben-Amotz D, low PS. Optical imaging of metastatic tumors using a folate-targeted uorescent probe. J Biomed Opt 2003;8:636- 641.
Altintas I, Kok RJ, Schi elers RM. Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies. Eur J Pharm Sci 2012;45:399- 407.
Choi HS, Gibbs SL, Lee JH et al. Targeted zwitterionic near-infrared uorophores for improved optical imaging. Nat Biotechnol 2013;31:148-153.
Hyun H, Park MH, Owens EA et al. Structure- inherent targeting of near-infrared uorophores for parathyroid and thyroid gland imaging. Nat Med 2015;21:192-197.
35. Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM. Targeting tumors with nanobodies for cancer imaging and therapy. J Control Release 2013;172:607- 617.
36. Rosenthal EL, Warram JM, de BE et al. Safety and Tumor Speci city of Cetuximab- IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res 2015;21:3658- 3666.
37. Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Oncol 2007;25:2873-2883.
38. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival e ect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248- 1259.
39. Hoskins WJ, McGuire WP, Brady MF et al. The e ect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-979.
40. Barranger E, Antomarchi J, Chamorey E et al. E ect of Neoadjuvant Chemotherapy on the Surgical Treatment of Patients With Locally Advanced Breast Cancer Requiring Initial Mastectomy. Clin Breast Cancer 2015.
41. Soucy G, Belanger J, Leblanc G et al. Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact? J Am Coll Surg 2008;206:1116-1121.
42. Crane LM, Arts HJ, van OM et al. The e ect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Cell Oncol (Dordr ) 2012;35:9-18.
43. O’Shannessy DJ, Somers EB, Maltzman J, Smale R, Fu YS. Folate receptor alpha (FRA) expression in breast cancer: identi cation of a new molecular subtype and association with triple negative disease. Springerplus 2012;1:22.
44. van Driel PB, van de Giessen M, Boonstra MC et al. Characterization and evaluation of the artemis camera for uorescence- guided cancer surgery. Mol Imaging Biol 2015;17:413-423.
45. Zhang Z, Wang J, Tacha DE et al. Folate receptor alpha associated with triple- negative breast cancer and poor prognosis. Arch Pathol Lab Med 2014;138:890-895.
46. Monici M, Basile V, Romano G et al. Fibroblast auto uorescence in connective tissue disorders: a future tool for clinical and di erential diagnosis? J Biomed Opt 2008;13:054025.